Julie Rae

High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR

Robert L. Shields, Angela K. Namenuk, Kyu Hong et al. · Journal of Biological Chemistry · 2001 · 1.2K citations · Full text

Pharmacy, Immunology, Molecular Biology +17

Ischemic Stroke Injury Is Reduced in Mice Lacking a Functional NADPH Oxidase

Claire E. Walder, Simon P. Green, Walter C. Darbonne et al. · Stroke · 1997 · 351 citations

Life Sciences, Neurobiology, Neuroscience +15

Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

Charles B. Foster, Thomas Lehrnbecher, Femke Mol et al. · Journal of Clinical Investigation · 1998 · 241 citations · Full text

Life Sciences, Immunology, Pathology +17

X-Linked Chronic Granulomatous Disease: Mutations in the CYBB Gene Encoding the gp91-phox Component of Respiratory-Burst Oxidase

Julie Rae, Peter E. Newburger, Mary C. Dinauer et al. · The American Journal of Human Genetics · 1998 · 212 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

David Isenberg, Richard Furie, Nicholas S. Jones et al. · Arthritis & Rheumatology · 2021 · 134 citations

Medicine, Pharmacology, Pharmacotherapy +16